Skip to main content
Equibles

CANADA PENSION PLAN INVESTMENT BOARD

Pension

Position in LYEL — Lyell Immunopharma, Inc.

CIK 1283718 TORONTO ONTARIO, A6
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$413,224
-$176,760 QoQ
Shares Held
29,411
0.0% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 87 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CANADA PENSION PLAN INVESTMENT BOARD holds $1,122,840,645 across 119 Biotechnology names. LYEL ranks #58 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 355,082 $176,379,881
2 KLRA
Kailera Therapeutics, Inc.
 7,304,688 $160,922,276
3 REGN
Regeneron Pharmaceuticals, Inc.
 209,911 $130,887,904
4 ALNY
Alnylam Pharmaceuticals, Inc.
 334,246 $100,618,073
5 ARGX
Argenx SE
 60,577 $56,201,523
6 AXSM
Axsome Therapeutics, Inc.
 225,400 $55,171,158
7 INCY
Incyte Corp
 442,500 $50,161,800
8 SPTX
Seaport Therapeutics, Inc.
 1,975,791 $42,914,180

All Filings in LYEL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $413,224 29,411
2026-03-31 $589,984 29,411
2025-12-31 $988,376 32,111
2025-09-30 $477,634 29,411
2025-06-30 $259,993 29,411
2025-03-31 $316,470 588,235
2024-12-31 $376,470 588,235
2024-09-30 $811,764 588,235
2024-06-30 $852,940 588,235
2024-03-31 $1,311,764 588,235
2023-12-31 $1,141,175 588,235
2023-09-30 $864,705 588,235
2023-06-30 $1,870,587 588,235
2023-03-31 $1,388,234 588,235
2022-12-31 $2,041,175 588,235
2022-09-30 $4,311,762 588,235
2022-06-30 $3,835,292 588,235
2022-03-31 $2,970,586 588,235
2021-12-31 $4,552,938 588,235
2021-09-30 $8,705,878 588,235
2021-06-30 $9,552,936 588,235